Dr. Weinberg is very involved in this project that I posted
Dr. Weinberg is very involved in this project that I posted yesterday!
I posted this yesterday just a reminder that this is a very interesting piece of the puzzle for CRC. I’m not saying we have funding from here but it’s worth a read if people didn’t see me drop it.
I just want to thank all the MD and others making these things happen or even possible!
Dr. Weinberg is a stand up guy. There is a video of him talking about this project. I’m not going to dig it up but take a peak if you can find it.
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...
Continue Reading
The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...
Continue Reading
Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...
Continue Reading
Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...
Continue Reading
Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...
Continue Reading
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue Reading
A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...
Continue Reading
A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...
Continue Reading
Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...
Continue Reading
Top 5 Most Recently Viewed Articles
Trex Company, Inc. Under Scrutiny for Securities Violations Trex Company, Inc. (NYSE: TREX) is currently facing an investigation regarding potential violations of federal securities laws. This inquiry is being conducted by the Law Offices of Howard G. Smith. The investigation stems from the company's recent financial disclosures, which raised concerns among investors....
Continue Reading
IRONMAN Partners with Experience Oman for a Dynamic Future The recent alliance between IRONMAN and Experience Oman marks a groundbreaking development in the realm of sports tourism. This partnership sets the stage for the prestigious IRONMAN 70.3 World Championship to take place in Oman, specifically in its capital of Muscat. Through this collaboration, Experience Oman...
Continue Reading
Introducing Quantic Bitcoin by Quantica Tech Quantica Tech, renowned for its innovations in quantum computing for blockchain, has embarked on an exciting project: Quantic Bitcoin (BTCQ). This initiative signifies a major leap towards integrating quantum computing capabilities into the decentralized finance landscape. With the development of a unique quantum...
Continue Reading
Assessing the Reliability of Bisnow's NYC Real Estate Reporting In the fast-paced world of New York City's real estate market, the accuracy of information plays a crucial role for various stakeholders, including investors, lenders, and policy-makers. These groups rely heavily on precise reporting to navigate the complex and often unpredictable regulatory landscape....
Continue Reading
Citi Analysts Recommend Buying Microsoft After Share Pullback Recent insights from analysts at Citi suggest that investors should consider purchasing Microsoft (NASDAQ: MSFT) shares following a notable price drop. They believe this presents an opportunity, highlighting potential upside in the coming quarters for the tech giant. Understanding Microsoft’s Current...
Continue Reading